Search Results

Strategic Overload Weakens Biotech Fundraising Signal 👉 Biotech fundraising is not only an evaluation of science And uncertainty, even when the science is strong, slows biotech fundraising more than most founders expect The science supports it. The data is promising. The market opportunity is real.

delivers trusted, razor-sharp insight to help drug discovery professionals like you stay ahead of the science Terry’s Pharmacology Corner  is your trusted, expert-led guide through the evolving landscape of GPCR science

As a lab technician at Johns Hopkins, he was fascinated by science but also grounded in real-life responsibilities

built a global network of researchers, biotech leaders, and pharma innovators who believe that GPCR science biotech leaders, CRO professionals, and investors from around the globe meet Boston’s vibrant life sciences

His work highlights how foundational GPCR science can drive therapeutic innovation.

Why this matters: Secure your voice in the next chapter of GPCR science.   Target ➤ What our community is saying “I enjoy the breadth of questioning that goes beyond just the science

GPCR Podcast on Self-Learning, Collaboration, and Delegation in Science with Dr. 7, 2024 | Chemotactic Cytokines June 4, 2024 | Live Webinar ‘It All Starts With a Protein – Protein Sciences Receptor Pharmacology PostDoctoral Scientist Senior Research Associate/Associate Scientist, Protein Science

rethinking how simulations, docking, and machine learning can transform GPCR research from descriptive science With rigor, transparency, and cross-disciplinary collaboration, they’re pushing GPCR science toward a

If you’re in GPCR discovery or biotech R&D, this is a masterclass in turning deep science into scalable And for those on the front lines of GPCR science, it’s a new lens to see what’s always been there—just

A Call for Patient-First Science Serafini’s strategy isn’t just about method — it’s about mindset.

This week's highlights: Driving Pharma Innovation in Oncology: Domain Therapeutics' Success Proven by Science Without Side Effects Driving Pharma Innovation in Oncology: Domain Therapeutics' Success Proven by Science Robert Lefkowitz Lab Senior Research Specialist - Natural Sciences - Surgery Senior Scientist- Membrane

How CRO Communication Impacts GPCR Drug Development Success Even the best science falters without operational Grassroots science drives the agenda.”

Peter joined Tectonic to help chart new territory in GPCR science.

He received his undergraduate Bachelor of Science Degree in Pharmacy from The Philadelphia College of Pharmacy and Science.

GPCR delivers every week: practical tools and critical intelligence to elevate your science and sharpen Designed for GPCR scientists and translational teams, Premium keeps you informed on the science, careers

—Alessandro Nicoli Want to explore computational GPCR science yourself?

Kenakin explains, pharmacology differs from other life sciences precisely because it builds quantitative Yet failure is not a sign of weakness in discovery science.

It captures our values and vision for the future, our culture, and our unique approach to science.

Proceedings of the National Academy of Sciences, 2017. 114(14): p. 3756-3761. 3.      Science, 2020. 369(6503). 4.     

Financing to Advance Pipeline of Novel GPCR-targeted Medicines OMass Therapeutics was shortlisted for ‘Life Sciences Channels, and Transport Proteins (March 24 - 29, 2024) GPCR Jobs NEW Senior Research Specialist - Natural Sciences

of Chemistry and Founder of (and ongoing consultant to) OMass Therapeutics, which is based at Oxford Science

Industry News Anatole Klepatsky, Orion's COO, Shared Innovative Insights at LSBC Central European Life Science in Database Development at Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences

At-the-Market Andrew Hopkins, Exscientia’s founder and CEO was elected a Fellow of the Academy of Medical Sciences (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference.

demographics are finally included, this represents a building block to reinforce the need for diversity in science New Insights Members Torsten Schöneberg and Ines Liebscher present an interactive browser-based application

Yet some assumptions still shaping pharmacology workflows haven’t evolved as fast as today’s science.

Trends in Pharmacological Sciences. 30.         Science signaling. 2024;17(841):eadi4747. 37.         Science signaling. 2024;17(843):eabq7038. 38.         Science advances. 2022;8(23):eabo4158. 53.         Carroll S. In the Pipeline  (Science, 2024).  

common sources of internal drift in early biotech teams: 1️⃣ Scientific versus commercial vision 👉 Your science You communicate with investors without rewriting your story every month. ✅ Science doesn’t just advance

7, 2024 | Chemotactic Cytokines June 4, 2024 | Live Webinar ‘It All Starts With a Protein – Protein Sciences Receptor Pharmacology NEW PostDoctoral Scientist Senior Research Associate/Associate Scientist, Protein Science

International Journal of Molecular Sciences, 20(15). Sugiura, R., Satoh, R., & Takasaki, T. (2021). Proceedings of the National Academy of Sciences, 100(19), 10782-10787.

April 2022 "By Sophie Bradley | Apr 12, 2022 Summary Sophie Bradley, Translational Sciences Associate